Clinuvl Phrmaceu (CUVL) Stock Price, News & Analysis
Company Description
Clinuvl Phrmaceu (NASDAQ: CUVL) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $350.5M, ranking #4,026 among all listed U.S. companies by market cap.
CUVL has declined 6.1% over the past year, placing it at #2,516 in year-to-date performance among tracked companies. Shares last traded at $6.95.
This page collects what Stock Titan holds for CUVL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Clinuvl Phrmaceu (CUVL) stock last traded at $6.95, up 0.72% from the previous close. Over the past 12 months, the stock has lost 6.1%. At a market capitalization of $350.5M, CUVL is classified as a small-cap stock with approximately 50.4M shares outstanding.
CUVL Rankings
Latest News
Clinuvl Phrmaceu has 2 recent news articles, with the latest published 2 days ago. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CUVL news →
SEC Filings
Financial Highlights
Upcoming Events
Headquarters relocation
Workforce reduction
Clinuvl Phrmaceu has 2 upcoming scheduled events. The next event, "Headquarters relocation", is scheduled for January 1, 2027 (in 159 days). Investors can track these dates to stay informed about potential catalysts that may affect the CUVL stock price.
Short Interest History
Days to Cover History
CUVL Company Profile & Sector Positioning
Clinuvl Phrmaceu (CUVL) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. In monthly performance, the stock ranks #2,668 among all tracked companies.